<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:53:36Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8165601" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8165601</identifier>
        <datestamp>2021-06-03</datestamp>
        <setSpec>transb</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Philos Trans R Soc Lond B Biol Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Philos Trans R Soc Lond B Biol Sci</journal-id>
              <journal-id journal-id-type="publisher-id">RSTB</journal-id>
              <journal-id journal-id-type="hwp">royptb</journal-id>
              <journal-title-group>
                <journal-title>Philosophical Transactions of the Royal Society B: Biological Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0962-8436</issn>
              <issn pub-type="epub">1471-2970</issn>
              <publisher>
                <publisher-name>The Royal Society</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8165601</article-id>
              <article-id pub-id-type="pmcid">PMC8165601</article-id>
              <article-id pub-id-type="pmc-uid">8165601</article-id>
              <article-id pub-id-type="pmid">34053258</article-id>
              <article-id pub-id-type="pmid">34053258</article-id>
              <article-id pub-id-type="doi">10.1098/rstb.2020.0282</article-id>
              <article-id pub-id-type="publisher-id">rstb20200282</article-id>
              <article-categories>
                <subj-group subj-group-type="discipline-codes">
                  <compound-subject>
                    <compound-subject-part content-type="code">1001</compound-subject-part>
                  </compound-subject>
                </subj-group>
                <subj-group subj-group-type="subject-codes">
                  <compound-subject>
                    <compound-subject-part content-type="code">87</compound-subject-part>
                  </compound-subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Articles</subject>
                </subj-group>
                <subj-group subj-group-type="type-of-publication">
                  <subject>Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Optimizing time-limited non-pharmaceutical interventions for COVID-19 outbreak control</article-title>
                <alt-title alt-title-type="short">Optimising COVID-19 interventions</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-5740-9734</contrib-id>
                  <name>
                    <surname>Morgan</surname>
                    <given-names>Alex L. K.</given-names>
                  </name>
                  <email>alex.morgan@ed.ac.uk</email>
                  <xref rid="af1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Woolhouse</surname>
                    <given-names>Mark E. J.</given-names>
                  </name>
                  <xref rid="af2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Medley</surname>
                    <given-names>Graham F.</given-names>
                  </name>
                  <xref rid="af3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-2177-7073</contrib-id>
                  <name>
                    <surname>van Bunnik</surname>
                    <given-names>Bram A. D.</given-names>
                  </name>
                  <xref rid="af2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <aff id="af1">
                  <label>
                    <sup>1</sup>
                  </label>
                  <addr-line><institution>Centre for Immunity, Infection and Evolution and School of Biological Sciences, University of Edinburgh</institution>, Edinburgh, <country>UK</country></addr-line>
                </aff>
                <aff id="af2">
                  <label>
                    <sup>2</sup>
                  </label>
                  <addr-line><institution>Usher Institute, University of Edinburgh</institution>, Edinburgh, <country>UK</country></addr-line>
                </aff>
                <aff id="af3">
                  <label>
                    <sup>3</sup>
                  </label>
                  <addr-line><institution>Centre for Mathematical Modelling of Infectious Diseases and Department of Global Health and Development, London School of Hygiene and Tropical Medicine</institution>, London, <country>UK</country></addr-line>
                </aff>
              </contrib-group>
              <author-notes>
                <fn fn-type="other">
                  <p>One contribution of 21 to a theme issue ‘<ext-link xlink:href="http://dx.doi.org/10.1098/rstb/376/1829" ext-link-type="uri">Modelling that shaped the early COVID-19 pandemic response in the UK</ext-link>’.</p>
                </fn>
                <fn fn-type="other">
                  <p>Electronic supplementary material is available online at <uri xlink:href="https://doi.org/10.6084/m9.figshare.c.5421425">https://doi.org/10.6084/m9.figshare.c.5421425</uri>.</p>
                </fn>
              </author-notes>
              <pub-date publication-format="print" date-type="pub">
                <day>19</day>
                <month>7</month>
                <year>2021</year>
                <string-date>July 19, 2021</string-date>
              </pub-date>
              <pub-date publication-format="electronic" date-type="pub">
                <day>31</day>
                <month>5</month>
                <year>2021</year>
                <string-date>May 31, 2021</string-date>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>31</day>
                <month>5</month>
                <year>2021</year>
                <string-date>May 31, 2021</string-date>
              </pub-date>
              <volume>376</volume>
              <issue>1829</issue>
              <issue-title><named-content content-type="issue-type">Theme issue</named-content> ‘Modelling that shaped the early COVID-19 pandemic response in the UK’ <named-content content-type="editors">compiled and edited by Ellen Brooks-Pollock, Leon Danon, Thibaut Jombart and Lorenzo Pellis</named-content></issue-title>
              <elocation-id>20200282</elocation-id>
              <history>
                <date date-type="accepted">
                  <day>7</day>
                  <month>1</month>
                  <year>2021</year>
                  <string-date>January 7, 2021</string-date>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 The Authors.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Published by the Royal Society under the terms of the Creative Commons Attribution License <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits unrestricted use, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="rstb.2020.0282.pdf"/>
              <abstract>
                <p>Retrospective analyses of the non-pharmaceutical interventions (NPIs) used to combat the ongoing COVID-19 outbreak have highlighted the potential of optimizing interventions. These optimal interventions allow policymakers to manage NPIs to minimize the epidemiological and human health impacts of both COVID-19 and the intervention itself. Here, we use a susceptible–infectious–recovered (SIR) mathematical model to explore the feasibility of optimizing the duration, magnitude and trigger point of five different NPI scenarios to minimize the peak prevalence or the attack rate of a simulated UK COVID-19 outbreak. An optimal parameter space to minimize the peak prevalence or the attack rate was identified for each intervention scenario, with each scenario differing with regard to how reductions to transmission were modelled. However, we show that these optimal interventions are fragile, sensitive to epidemiological uncertainty and prone to implementation error. We highlight the use of robust, but suboptimal interventions as an alternative, with these interventions capable of mitigating the peak prevalence or the attack rate over a broader, more achievable parameter space, but being less efficacious than theoretically optimal interventions. This work provides an illustrative example of the concept of intervention optimization across a range of different NPI strategies.</p>
                <p>This article is part of the theme issue ‘Modelling that shaped the early COVID-19 pandemic response in the UK’.</p>
              </abstract>
              <kwd-group>
                <kwd>COVID-19</kwd>
                <x xml:space="preserve">, </x>
                <kwd>modelling</kwd>
                <x xml:space="preserve">, </x>
                <kwd>optimization</kwd>
                <x xml:space="preserve">, </x>
                <kwd>epidemiology/non-pharmaceutical interventions</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution>Wellcome Trust</institution>
                      <institution-id>http://dx.doi.org/10.13039/100004440</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>215094/Z/18/Z</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>July 19, 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="s1">
              <label>1<x xml:space="preserve">. </x></label>
              <title>Introduction</title>
              <p>The ongoing COVID-19 pandemic has highlighted the vital role of non-pharmaceutical interventions (NPIs) in mitigating the spread of SARS-CoV-2. These interventions aim to break chains in transmission through population-and individual-level behavioural changes, which can consequently reduce opportunities for transmission [<xref rid="RSTB20200282C1" ref-type="bibr">1</xref>]. NPIs encompass a large range of potential outbreak control strategies, ranging from simple advice to encourage hand-washing to country-wide, severe ‘lockdown’ measures such as stay-at-home orders, mobility restrictions and closure of non-essential businesses [<xref rid="RSTB20200282C2" ref-type="bibr">2</xref>].</p>
              <p>While an effective tool to drive down disease prevalence, severe NPIs are considered unsustainable and time-limited, with economic, physical and mental health repercussions during and following the cessation of these interventions [<xref rid="RSTB20200282C3" ref-type="bibr">3</xref>–<xref rid="RSTB20200282C5" ref-type="bibr">5</xref>]. This has driven calls to retrospectively understand the epidemiological and human health impacts of introducing severe NPIs under a different set of circumstances [<xref rid="RSTB20200282C6" ref-type="bibr">6</xref>–<xref rid="RSTB20200282C8" ref-type="bibr">8</xref>]. This includes insight into how differences in the timing, duration and strength of these interventions could have potentially altered COVID-19-associated mortality and morbidity compared with the actual course of action.</p>
              <p>Intervention optimization has been proposed as a method to allow policymakers to fine-tune the characteristics of an intervention to minimize epidemiologically relevant outcome measures. Optimization has been explored for a range of potential COVID-19 NPI strategies, including single time-limited reductions to transmission [<xref rid="RSTB20200282C9" ref-type="bibr">9</xref>,<xref rid="RSTB20200282C10" ref-type="bibr">10</xref>], intermittent pulsing of NPIs [<xref rid="RSTB20200282C11" ref-type="bibr">11</xref>,<xref rid="RSTB20200282C12" ref-type="bibr">12</xref>] and gradual ramping-down of intervention measures following an initial reduction to transmission [<xref rid="RSTB20200282C12" ref-type="bibr">12</xref>–<xref rid="RSTB20200282C14" ref-type="bibr">14</xref>]. This has been explored in the context of minimizing the peak incidence or prevalence, analogous to ‘flattening the curve’ of an outbreak.</p>
              <p>Despite theoretically optimal interventions being identified in a number of optimization analyses for COVID-19, the ability for policymakers to achieve these results in practice has been questioned [<xref rid="RSTB20200282C10" ref-type="bibr">10</xref>]. This stems from the narrow windows for optimal implementation, with minor deviations from the optimal intervention timing, duration or magnitude often greatly reducing the efficacy of the NPI and therefore having severe human health consequences [<xref rid="RSTB20200282C10" ref-type="bibr">10</xref>,<xref rid="RSTB20200282C13" ref-type="bibr">13</xref>]. This sensitivity to implementation error is likely to be amplified in emerging outbreak situations such as the COVID-19 pandemic, with imperfect epidemiological knowledge of uncharacterized, novel pathogens preventing policymakers from fine-tuning NPIs to a narrow optimal parameter space. An alternative strategy is to use generalized intervention strategies that are, as an example, longer or earlier than the theoretically optimal parameter space [<xref rid="RSTB20200282C15" ref-type="bibr">15</xref>]. Such interventions can be denoted ‘robust’ interventions. The rationale behind these pragmatic interventions would be to identify a broad and achievable parameter space that may be suboptimal, but potentially more robust to implementation error, while still capable of mitigating the detrimental epidemiological impacts of COVID-19 [<xref rid="RSTB20200282C10" ref-type="bibr">10</xref>]. Owing to the robust and general nature of these interventions, they also offer more practical and flexible guidance to policymakers than specific optimal intervention timings or durations.</p>
              <p>This study aims to provide a mathematical modelling framework to explore the concept of optimal and robust interventions across a range of different NPI scenarios. We explore and compare the existence, patterns and optimal parameter spaces for each intervention to minimize the peak prevalence or the attack rate of a simulated outbreak. This is explored for three main parameters: (i) intervention duration, (ii) intervention strength, and (iii) the intervention trigger point. The results from this study are not intended to highlight an absolute best course of action. Rather, this analysis provides an illustrative example to describe how optimal and robust outbreak control can be achieved under different circumstances and intervention strategies.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <label>2<x xml:space="preserve">. </x></label>
              <title>Methods</title>
              <sec id="s2a">
                <label>(a)</label>
                <title>Susceptible–infectious–recovered model structure</title>
                <p>A deterministic susceptible–infectious–recovered (SIR) model [<xref rid="RSTB20200282C16" ref-type="bibr">16</xref>] was used to explore the impact of time-limited NPIs on a simulated UK-based COVID-19 outbreak. <italic toggle="yes">S</italic>, <italic toggle="yes">I</italic> and <italic toggle="yes">R</italic> compartments denote the fraction of susceptible, infectious and recovered individuals, respectively, within the population (equation 2.1)<disp-formula id="RSTB20200282M2.1"><label>2.1</label><mml:math id="DM1" display="block"><mml:mrow><mml:mtable columnalign="right left" rowspacing=".5em" columnspacing="thickmathspace"><mml:mtr><mml:mtd><mml:mstyle><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mo> </mml:mo></mml:mstyle></mml:mtd><mml:mtd><mml:mo>−</mml:mo><mml:mi>β</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mstyle><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mo> </mml:mo></mml:mstyle></mml:mtd><mml:mtd><mml:mi>β</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>−</mml:mo><mml:mi>γ</mml:mi><mml:mi>I</mml:mi><mml:mo> </mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mi mathvariant="normal">and</mml:mi></mml:mrow><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:mspace width="2em"/><mml:mstyle><mml:mrow><mml:mfrac><mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mo> </mml:mo></mml:mstyle></mml:mtd><mml:mtd><mml:mi>γ</mml:mi><mml:mi>I</mml:mi><mml:mo> </mml:mo><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable><mml:mo>}</mml:mo></mml:mrow></mml:math></disp-formula>Susceptible individuals (<italic toggle="yes">S</italic>) were infected at the time-varying rate <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>), representing the daily <italic toggle="yes">per capita</italic> rate of transmission in a randomly mixing population. Infectious individuals (<italic toggle="yes">I</italic>) were assumed to recover at rate <italic toggle="yes">γ</italic>, representing the daily <italic toggle="yes">per capita</italic> rate of recovery. This rate was taken as the inverse of the average duration of infectiousness. A baseline pre-NPI basic reproduction number (<italic toggle="yes">R</italic><sub>0</sub>) of 2.8 and doubling time (<italic toggle="yes">T</italic><sub>d</sub>) of 3 days were assumed [<xref rid="RSTB20200282C17" ref-type="bibr">17</xref>–<xref rid="RSTB20200282C21" ref-type="bibr">21</xref>]. The generation time was calculated as a function of these two quantities [<xref rid="RSTB20200282C22" ref-type="bibr">22</xref>], with a baseline generation time of 7.79 days and a resulting <italic toggle="yes">γ</italic> of 0.128 day<sup>−1</sup> (equation 2.2)<disp-formula id="RSTB20200282M2.2"><label>2.2</label><mml:math id="DM2" display="block"><mml:mrow><mml:mi mathvariant="normal">Generation</mml:mi><mml:mo> </mml:mo></mml:mrow><mml:mo> </mml:mo><mml:mrow><mml:mi mathvariant="normal">time</mml:mi></mml:mrow><mml:mo> </mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:msub><mml:mstyle><mml:mrow><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">ln</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:mrow><mml:mo>.</mml:mo></mml:mstyle></mml:math></disp-formula></p>
              </sec>
              <sec id="s2b">
                <label>(b)</label>
                <title>Defining the time-varying <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>)</title>
                <p>By setting <italic toggle="yes">β</italic> = <italic toggle="yes">R</italic><sub>0</sub><italic toggle="yes">γ</italic>, we defined the baseline <italic toggle="yes">per capita</italic> transmission rate in the absence of NPIs, <italic toggle="yes">β</italic> = 0.359 day<sup>−1</sup>. To capture the impact of smaller scale NPIs, <italic toggle="yes">β</italic> was multiplied by a scaling factor of 0.7, <italic toggle="yes">β</italic><sub>scale</sub> = 0.252 day<sup>−1</sup>, with this 30% reduction being in line with estimates of the impact of NPIs, such as school-closures, introduction of social distancing and isolation upon COVID-19 symptoms and excluding severe NPIs, such as stay-at-home orders [<xref rid="RSTB20200282C21" ref-type="bibr">21</xref>,<xref rid="RSTB20200282C23" ref-type="bibr">23</xref>,<xref rid="RSTB20200282C24" ref-type="bibr">24</xref>]. We assumed that these measures were in place at the initiation of the model simulation. Using the UK as a representative example, these measures were introduced between 12 and 21 March 2020, with severe ‘lockdown’ measures initiated on 25 March 2020 [<xref rid="RSTB20200282C24" ref-type="bibr">24</xref>]. However, it was not the intention of this study to model the exact timing of the UK outbreak response, rather to use the epidemiological characteristics of the UK outbreak as motivation for this study.</p>
                <p><italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>) was defined as the product of <italic toggle="yes">β</italic><sub>scale</sub> and a time-varying scaling factor <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>), which reduced <italic toggle="yes">β</italic><sub>scale</sub> over the course of the simulation to model the impact of severe NPI measures, with 0 ≤ <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) ≤ 1 (equation (2.3)). Reductions associated with this scaling factor were introduced at the intervention trigger point, <italic toggle="yes">t</italic><sub>p</sub>, and with <italic toggle="yes">d<sub>t</sub></italic> describing the duration of the intervention<disp-formula id="RSTB20200282M2.3"><label>2.3</label><mml:math id="DM3" display="block"><mml:mi>β</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mi>c</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mtable rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">scale</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mspace width="-3.2pc"/><mml:mrow><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">scale</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mo> </mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>≤</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">scale</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mspace width="-1.2pc"/><mml:mrow><mml:mi>t</mml:mi><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></disp-formula>The shape of the <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) factor varied with the different intervention scenarios explored, with parameter <italic toggle="yes">c</italic><sub>min</sub> describing the minimum value of <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) during the intervention. This can be considered a proxy measure of the magnitude of the intervention. For baseline reductions to <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>), we defined <italic toggle="yes">c</italic><sub>min</sub> = 0.4, resulting in <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>) = 0.101 when the NPI measures are at their greatest magnitude<italic toggle="yes">.</italic> Baseline <italic toggle="yes">c</italic><sub>min</sub> was chosen to roughly achieve an effective reproduction number (<italic toggle="yes">R</italic><sub>e</sub>) of 0.7 ≤ <italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) ≤ 1 during the intervention [<xref rid="RSTB20200282C21" ref-type="bibr">21</xref>,<xref rid="RSTB20200282C23" ref-type="bibr">23</xref>,<xref rid="RSTB20200282C24" ref-type="bibr">24</xref>], with <italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) defined as <italic toggle="yes">R</italic><sub>0</sub><italic toggle="yes">S</italic>(<italic toggle="yes">t</italic>). All interventions were initiated at baseline <italic toggle="yes">t</italic><sub>p</sub> = 52 days, equivalent to an attack rate at the initiation of the severe NPI measures of <italic toggle="yes">I<sub>c</sub></italic>(52) = 0.02, in line with model-based UK COVID-19 estimates [<xref rid="RSTB20200282C24" ref-type="bibr">24</xref>]. The model was seeded with an initial infectious fraction <italic toggle="yes">I</italic>(0) = 0.00001.</p>
              </sec>
              <sec id="s2c">
                <label>(c)</label>
                <title>Single period of severe non-pharmaceutical interventions</title>
                <p>A time-limited period of severe NPI measures was the primary intervention explored in this model, with optimization occurring in relation to this intervention. We explored five different intervention scenarios, with each scenario differing with regard to the shape of <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) and the subsequent <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>) reductions over the duration of the intervention (<italic toggle="yes">d<sub>t</sub></italic>) (<xref rid="RSTB20200282TB1" ref-type="table">table 1</xref>). The total duration of the simulation, <italic toggle="yes">t</italic><sub>max</sub>, was set at 400 and 1000 days for all other sensitivity analyses. We provide the rationale and real-world parallels for each scenario in the electronic supplementary material, p. 1.
<table-wrap position="float" id="RSTB20200282TB1"><label>Table 1<x xml:space="preserve">. </x></label><caption><p>Description of the five intervention scenarios.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1">scenario</th><th align="left" rowspan="1" colspan="1">description of <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>)</th><th align="left" rowspan="1" colspan="1">definition of <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">immediate and constant reduction to <italic toggle="yes">c</italic><sub>min</sub></td><td rowspan="1" colspan="1"><inline-formula><mml:math id="IM1"><mml:mi>c</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">immediate reduction to <italic toggle="yes">c</italic><sub>min</sub> followed by a linear increase back to <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) = 1</td><td rowspan="1" colspan="1"><inline-formula><mml:math id="IM2"><mml:mi>c</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mstyle displaystyle="true"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mstyle></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">linear decrease to <italic toggle="yes">c</italic><sub>min</sub> followed by an immediate return to <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) = 1</td><td rowspan="1" colspan="1"><inline-formula><mml:math id="IM3"><mml:mi>c</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mstyle displaystyle="true"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mstyle></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">linear decrease to <italic toggle="yes">c</italic><sub>min</sub> at <italic toggle="yes">d<sub>t</sub></italic>/2, followed by a linear increase back to <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) = 1</td><td rowspan="1" colspan="1"><inline-formula><mml:math id="IM4"><mml:mi>c</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mtable rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mspace width="-20pt"/><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mstyle displaystyle="true"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mrow><mml:mrow><mml:mo>/</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:mspace width="8pt"/><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mstyle><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:mstyle></mml:mstyle></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mstyle displaystyle="true"><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mrow><mml:mrow><mml:mo>/</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo><mml:mo> </mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mstyle><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>≤</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mstyle></mml:mstyle></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></inline-formula></td></tr><tr><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">a ‘pulsing’ intervention with immediate reductions to <italic toggle="yes">c</italic><sub>min</sub> between intervention intervals 0–21, 35–49 and 63–77 days (for an example total intervention duration, <italic toggle="yes">d<sub>t</sub></italic> = 84 days)</td><td rowspan="1" colspan="1"><inline-formula><mml:math id="IM5"><mml:mi>c</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mtable rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>2</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>2</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>3</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>3</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>4</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">min</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>4</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>≤</mml:mo><mml:mi>t</mml:mi><mml:mo>&lt;</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>5</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mi>t</mml:mi><mml:mo>≥</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mfrac><mml:mn>5</mml:mn><mml:mn>6</mml:mn></mml:mfrac></mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></inline-formula></td></tr></tbody></table></table-wrap></p>
                <p>For a given intervention duration, <italic toggle="yes">d<sub>t</sub></italic>, the magnitude of <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) scaling reductions over the intervention duration was half for scenarios 2, 3, 4 and 5 relative to scenario 1. To maintain comparable <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>) reductions over the intervention period, <italic toggle="yes">d<sub>t</sub></italic> was doubled for scenarios 2, 3, 4 and 5 relative to scenario 1 for baseline analyses. This corresponds to <italic toggle="yes">d<sub>t</sub></italic> = 84 days for scenario 1 (12 weeks) and <italic toggle="yes">d<sub>t</sub></italic> = 168 days (24 weeks) for all other scenarios. However, we note this was not possible in sensitivity analyses where <italic toggle="yes">d<sub>t</sub></italic> was an explored parameter. Instead, the <italic toggle="yes">d<sub>t</sub></italic> range for scenario 1 was transformed into a relative axis to enable comparisons across scenarios. This was achieved by halving the explored <italic toggle="yes">d<sub>t</sub></italic> range for scenario 1 relative to all other scenarios, and then doubling the absolute values in this limited <italic toggle="yes">d<sub>t</sub></italic> range into a relative scale. As an illustrative example, an absolute value of <italic toggle="yes">d<sub>t</sub></italic> = 125 is equal to a relative value of <italic toggle="yes">d<sub>t</sub></italic> = 250 for scenario 1. Baseline parameter values for the modelling of single NPIs can be found in electronic supplementary material, table S1.</p>
                <p>An alternative approach was considered by keeping <italic toggle="yes">d<sub>t</sub></italic> constant and doubling <italic toggle="yes">c</italic><sub>min</sub> in scenarios 2, 3, 4 and 5 relative to scenario 1 (electronic supplementary material, figures S1 and S2). However, in practice, it is likely more plausible to alter <italic toggle="yes">d<sub>t</sub></italic> than it is to alter <italic toggle="yes">c</italic><sub>min</sub> in a public health context. This can be attributed to difficulty faced by policymakers to introduce an intervention with a specific magnitude or strength [<xref rid="RSTB20200282C25" ref-type="bibr">25</xref>].</p>
              </sec>
              <sec id="s2d">
                <label>(d)</label>
                <title>Multiple non-pharmaceutical interventions</title>
                <p>To explore the transmission dynamics resulting from multiple, time-limited periods of severe NPIs, two interventions were modelled for each scenario sequentially during the simulation. We defined the minimum value of the <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) scaling factor, trigger point and duration of the intervention as <italic toggle="yes">c</italic><sub>min1</sub> and <italic toggle="yes">c</italic><sub>min2</sub>, <italic toggle="yes">t</italic><sub>p</sub><sub>1</sub> and <italic toggle="yes">t</italic><sub>p</sub><sub>2</sub>, and <italic toggle="yes">d<sub>t</sub></italic><sub>1</sub> and <italic toggle="yes">d<sub>t</sub></italic><sub>2<italic toggle="yes">,</italic></sub> respectively, for interventions 1 and 2. We note that <italic toggle="yes">t<sub><italic toggle="yes">p</italic>2</sub></italic> is defined relative to the end of intervention 1, with the start of intervention 2 defined as <italic toggle="yes">t</italic> = <italic toggle="yes">t</italic><sub>p</sub><sub>1</sub> + <italic toggle="yes">d<sub>t</sub></italic><sub>1</sub> + <italic toggle="yes">t</italic><sub>p</sub><sub>2</sub>.</p>
                <p>Baseline parameter values for the multi-intervention scenario were set at <italic toggle="yes">d<sub>t</sub></italic><sub>1</sub> = <italic toggle="yes">d<sub>t</sub></italic><sub>2</sub> = 42 days (6 weeks) for scenario 1 and <italic toggle="yes">d<sub>t</sub></italic><sub>1</sub> = <italic toggle="yes">d<sub>t</sub></italic><sub>2</sub> = 84 days (12 weeks) for scenarios 2, 3, 4 and 5. This was halved relative to the single-intervention scenarios to allow the two interventions to occur within the timeframe of the simulated outbreak and to prevent unfeasibly long overall intervention durations. We note that comparisons between the single-and multi-intervention scenarios should be limited to the general qualitative pattern of the optimal parameter space, rather than being direct quantitative comparisons. The minimum value of the scaling factor <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) was kept constant at <italic toggle="yes">c</italic><sub>min1</sub> = <italic toggle="yes">c</italic><sub>min2</sub> = 0.4 at baseline. Baseline parameter values for the modelling of multiple NPIs can be found in electronic supplementary material, table S2.</p>
              </sec>
              <sec id="s2e">
                <label>(e)</label>
                <title>Outcome measures of interest</title>
                <p>The primary objective of all analyses in this study was to identify the optimal parameter space for the intervention trigger point (<italic toggle="yes">t</italic><sub>p</sub>), duration (<italic toggle="yes">d<sub>t</sub></italic>) and magnitude (c<sub>min</sub>) to minimize two outcome measures:
<list list-type="simple"><list-item><label>1<x xml:space="preserve">. </x><x xml:space="preserve"> </x></label><p>peak <italic toggle="yes">I</italic>(<italic toggle="yes">t</italic>) prevalence: <inline-formula><mml:math id="IM6"><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">max</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:math></inline-formula><sub>,</sub></p></list-item><list-item><label>2<x xml:space="preserve">. </x><x xml:space="preserve"> </x></label><p>attack rate: <inline-formula><mml:math id="IM7"><mml:msub><mml:mi>I</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">max</mml:mi></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo> </mml:mo><mml:mo>=</mml:mo><mml:munder><mml:mrow><mml:mo movablelimits="true">lim</mml:mo></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo stretchy="false">→</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mo movablelimits="true">max</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:munder><mml:mo>⁡</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math></inline-formula>.</p></list-item></list></p>
                <p>We defined <italic toggle="yes">I</italic><sub>max</sub> as the global maximum of the function describing the trajectory of the fraction infectious during the simulated epidemic, with subsequent references to ‘epidemic peaks’ describing the local maxima where <italic toggle="yes">I</italic>(<italic toggle="yes">t</italic>) &gt; 0 and <italic toggle="yes">I'</italic>(<italic toggle="yes">t</italic>) = 0. The attack rate, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), was defined as the total proportion of cases that develop over the model simulation duration. The optimal parameter space was defined as the combination of parameter values that resulted in the lowest possible value of <italic toggle="yes">I</italic><sub>max</sub> or <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>).</p>
              </sec>
              <sec id="s2f">
                <label>(f)</label>
                <title>Software used</title>
                <p>All simulations were carried out using R [<xref rid="RSTB20200282C26" ref-type="bibr">26</xref>] and RStudio [<xref rid="RSTB20200282C27" ref-type="bibr">27</xref>]. R package ‘deSolve’ [<xref rid="RSTB20200282C28" ref-type="bibr">28</xref>] was used for all model simulations. All other R packages used for plotting can be found in the electronic supplementary material.</p>
              </sec>
            </sec>
            <sec id="s3">
              <label>3<x xml:space="preserve">. </x></label>
              <title>Results</title>
              <p>The impact of the five intervention scenarios on the trajectory of a simulated COVID-19 outbreak was explored (<xref rid="RSTB20200282F1" ref-type="fig">figure 1</xref><italic toggle="yes">a</italic>). Scenario 4 was identified as the most effective scenario at mitigating peak prevalence or the attack rate under baseline parameters (<italic toggle="yes">I</italic><sub>max</sub> = 0.076, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) = 0.493) relative to an unmitigated outbreak (<italic toggle="yes">I</italic><sub>max</sub> = 0.146, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) = 0.786). Scenarios 1 and 2 resulted in the suppression of the initial outbreak and delay in the epidemic peak following the initiation of intervention measures. By contrast, a single mitigated epidemic peak was observed for scenarios 3 and 4, with the steady ramping up of <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>) reductions and the protective effects of population immunity resulting in a more gradual, sustained reduction to <italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>), preventing peak resurgence. The pulsed nature of scenario 5 allowed brief opportunities for the build-up of population immunity (<italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) &gt; 1) and subsequent epidemic control (<italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) &lt; 1).
<fig position="float" id="RSTB20200282F1"><label>Figure 1<x xml:space="preserve">. </x></label><caption><p>(<italic toggle="yes">a</italic>) Trajectory plots for the epidemic curve, <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>) reductions and <italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) for the five intervention scenarios. (<italic toggle="yes">b</italic>) Sensitivity analysis for intervention trigger point (<italic toggle="yes">t</italic><sub>p</sub>), magnitude (<italic toggle="yes">c</italic><sub>min</sub>) and duration (<italic toggle="yes">d<sub>t</sub></italic>) to minimize the peak prevalence, <italic toggle="yes">I</italic><sub>max</sub>, and attack rate, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>). For (<italic toggle="yes">a</italic>), pale red and blue lines depict unmitigated epidemic curve dynamics, blue shading indicates the intervention period and the dotted line depicts the <italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) = 1.0 threshold for sustained epidemic growth. <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) values are annotated for each scenario. Note that for (<italic toggle="yes">b</italic>), the <italic toggle="yes">d<sub>t</sub></italic> axis for scenario 1 was transformed into a relative axis to allow comparison across scenarios, with the relative axis of 0 ≤ <italic toggle="yes">d<sub>t</sub></italic> ≤ 400 being equal to an absolute <italic toggle="yes">d<sub>t</sub></italic> range of 0 ≤ <italic toggle="yes">d<sub>t</sub></italic> ≤ 200.</p></caption><graphic xlink:href="rstb20200282f01" position="float"/></fig></p>
              <p>Sensitivity analyses were conducted to observe the sensitivity of the peak prevalence, <italic toggle="yes">I</italic><sub>max</sub>, and the attack rate, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), to the intervention trigger point (<italic toggle="yes">t</italic><sub>p</sub>), magnitude (<italic toggle="yes">c</italic><sub>min</sub>) and duration (<italic toggle="yes">d<sub>t</sub></italic>) (<xref rid="RSTB20200282F1" ref-type="fig">figure 1</xref><italic toggle="yes">b</italic>). As an initial exploration into model dynamics, each parameter was investigated sequentially with all other model parameters held constant at baseline values. Optimal parameter values for all scenarios can be found summarized in electronic supplementary material, table S3.</p>
              <p>A specific optimal trigger point was observed for all scenarios to minimize both <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), with these optimal values found within an early-intermediate trigger point parameter space (7 ≤ <italic toggle="yes">t</italic><sub>p</sub> ≤ 74). While an optimum was identified for scenario 5 to minimize <italic toggle="yes">I</italic><sub>max</sub> (<italic toggle="yes">t</italic><sub>p</sub> = 53), two other trigger points resulted in similar reductions to <italic toggle="yes">I</italic><sub>max</sub> (<italic toggle="yes">t</italic><sub>p</sub> = 32 and 74). Scenarios 1, 3 and 4 were found to be highly sensitive to deviations from the optimal <italic toggle="yes">t</italic><sub>p</sub> value, with steep increases in <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) either side of the optimum. We note that if a suboptimal trigger point was chosen in scenario 2, it would be more beneficial to intervene earlier-than-optimal, with a gentler increase in <italic toggle="yes">I</italic><sub>max</sub> as <italic toggle="yes">t</italic><sub>p</sub> is reduced from the optimal value, compared with later-than-optimal <italic toggle="yes">t</italic><sub>p</sub> values.</p>
              <p>Stronger interventions resulted in optimal reductions to <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for scenarios 3 and 4 (<italic toggle="yes">c</italic><sub>min</sub> → 0). By contrast, intermediate-strength interventions were found to be optimal in scenarios 1, 2 and 5 (<italic toggle="yes">c</italic><sub>min</sub> = 0.72/0.77, 0.56/0.62, 0.27/0.47) for <italic toggle="yes">I</italic><sub>max</sub>/<italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), respectively. We note that if suboptimal intervention magnitudes were chosen for scenarios 1, 2 and 5, it was more beneficial to intervene too strongly than insufficiently. This was observed with decreases in <italic toggle="yes">c</italic><sub>min</sub> from the optimal value resulting in gentler increases in <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) compared with greater-than-optimal <italic toggle="yes">c</italic><sub>min</sub> values.</p>
              <p>Longer intervention durations were found to be optimal to reduce <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for scenario 2 (<italic toggle="yes">d<sub>t</sub></italic> → 400). Interestingly, increasing the intervention duration was found to have minimal impact on either outcome measure in scenario 1, with the cessation of the intervention resulting in an identically sized epidemic peak regardless of the intervention duration. By contrast, intermediate-length interventions were found to be optimal for scenarios 3 and 4 (<italic toggle="yes">d<sub>t</sub></italic> = 60/97, 100/174) for <italic toggle="yes">I</italic><sub>max</sub>/<italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), respectively, with scenario 5 displaying two relatively similar optimal points to minimize <italic toggle="yes">I</italic><sub>max</sub> (<italic toggle="yes">d<sub>t</sub></italic> = 104/175). We note that if a suboptimal intervention duration was introduced for these scenarios, it was better to intervene for too long, with increases in <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) being less severe in an intervention that was longer-than-optimal, compared with an intervention that was shorter-than-optimal.</p>
              <p>To explore the interplay between multiple model parameters, a sensitivity analysis was next conducted to identify the optimal parameter space to minimize <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for a multi-dimensional parameter space: (i) intervention trigger point (<italic toggle="yes">t</italic><sub>p</sub>) and (ii) intervention duration (<italic toggle="yes">d<sub>t</sub></italic>) (<xref rid="RSTB20200282F2" ref-type="fig">figure 2</xref>). The optimal parameter space for all scenarios can be found summarized in electronic supplementary material, table S3.
<fig position="float" id="RSTB20200282F2"><label>Figure 2<x xml:space="preserve">. </x></label><caption><p>Sensitivity analysis for the peak prevalence, <italic toggle="yes">I</italic><sub>max</sub>, and attack rate, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), for intervention trigger point, <italic toggle="yes">t</italic><sub>p</sub>, and duration, <italic toggle="yes">d<sub>t</sub></italic>. Note that the scenario 1 <italic toggle="yes">d<sub>t</sub></italic> axis was transformed into a relative axis to allow comparison across scenarios, with the relative axis of 0 ≤ <italic toggle="yes">d<sub>t</sub></italic> ≤ 250 being equal to an absolute <italic toggle="yes">d<sub>t</sub></italic> range of 0 ≤ <italic toggle="yes">d<sub>t</sub></italic> ≤ 125.</p></caption><graphic xlink:href="rstb20200282f02" position="float"/></fig></p>
              <p>A longer intervention duration (<italic toggle="yes">d<sub>t</sub></italic> → 250) and intermediate trigger point (<italic toggle="yes">t</italic><sub>p</sub> = 70/66 and <italic toggle="yes">t</italic><sub>p</sub> = 80) was optimal for scenarios 1 and 2, respectively, to minimize <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>). A contrasting pattern was observed in scenarios 3 and 4, with shorter intervention durations found to maintain a near-optimal parameter space with a later intervention trigger. We note the existence of suboptimal trigger point ‘gaps’ in scenario 5, with increases and decreases in <italic toggle="yes">I</italic><sub>max</sub> as the trigger point was varied. This resulted from the fixed periods between pulsed interventions, with these ‘gaps’ increasing as the duration of the overall intervention increased. These ‘gaps’ were found to be less pronounced for <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) relative to <italic toggle="yes">I</italic><sub>max</sub>. Increasing the duration of the intervention had compensatory effects for scenarios 2, 3, 4 and 5, with both <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) becoming less sensitive to deviations from the optimal intervention trigger point as the duration of the intervention was increased. This suggests that increasing the duration can make the intervention more robust to optimal trigger point implementation error.</p>
              <p>The sensitivity analysis was repeated with <italic toggle="yes">c</italic><sub>min</sub> = 0.25/0.5/0.75 to assess the sensitivity of the <italic toggle="yes">d<sub>t</sub></italic>/<italic toggle="yes">t</italic><sub>p</sub> relationship to alterations to the magnitude of the intervention (electronic supplementary material, figures S3 and S4). Low-to-intermediate <italic toggle="yes">c</italic><sub>min</sub> values of 0.25 (scenarios 1, 2 and 3) and 0.5 (scenarios 3 and 4) were found to be optimal to minimize <italic toggle="yes">I</italic><sub>max</sub>, with the lowest explored value of <italic toggle="yes">c</italic><sub>min</sub> being optimal to minimize <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for all scenarios.</p>
              <p>Two sequentially implemented interventions for each of the five scenarios were next modelled to explore the introduction of NPIs at a later date to tackle epidemic resurgence. Descriptive trajectory plots for each of the five multi-intervention scenarios can be found in electronic supplementary material, figure S5. We note a higher value of <italic toggle="yes">I</italic><sub>max</sub> for scenarios 2 and 5 and the existence of an increased number of epidemic peaks for scenarios 1 and 4 relative to the single-intervention scenarios. This can be attributable to the shorter intervention duration used for the multi-intervention scenarios.</p>
              <p>A sensitivity analysis was conducted for the multi-intervention model to explore the optimal parameter space to minimize <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for two sets of parameters: (i) interventions 1 and 2 trigger points, <italic toggle="yes">t</italic><sub>p</sub><sub>1</sub> and <italic toggle="yes">t</italic><sub>p</sub><sub>2</sub><italic toggle="yes">,</italic> and (ii) interventions 1 and 2 magnitudes, <italic toggle="yes">c</italic><sub>min1</sub> and <italic toggle="yes">c</italic><sub>min2</sub> (<xref rid="RSTB20200282F3" ref-type="fig">figure 3</xref>). The optimal parameter space for all scenarios can be found summarized in electronic supplementary material, table S3.
<fig position="float" id="RSTB20200282F3"><label>Figure 3<x xml:space="preserve">. </x></label><caption><p>(<italic toggle="yes">a</italic>) Sensitivity analysis for the peak prevalence, <italic toggle="yes">I</italic><sub>max</sub>, and attack rate, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), for intervention 1 trigger point, <italic toggle="yes">t</italic><sub>p</sub><sub>1</sub>, and intervention 2 trigger point, <italic toggle="yes">t</italic><sub>p</sub><sub>2</sub>. (<italic toggle="yes">b</italic>) Sensitivity analysis for the minimum value of scaling factor <italic toggle="yes">c</italic>(<italic toggle="yes">t</italic>) for intervention 1, <italic toggle="yes">c</italic><sub>min1</sub>, and intervention 2, <italic toggle="yes">c</italic><sub>min2</sub>.</p></caption><graphic xlink:href="rstb20200282f03" position="float"/></fig></p>
              <p>A large range of trigger points for intervention 2 (1 ≤ <italic toggle="yes">t</italic><sub>p</sub><sub>2</sub> ≤100) were found to result in near-optimal reductions to <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), on the condition that the optimal trigger point for intervention 1 was achieved (50 ≤ <italic toggle="yes">t</italic><sub>p</sub><sub>1</sub> ≤ 65) (<xref rid="RSTB20200282F3" ref-type="fig">figure 3</xref><italic toggle="yes">a</italic>). This was found to differ if an earlier-than-optimal intervention 1 trigger point was chosen, with only a narrow selection of optimal intervention 2 trigger points able to compensate for a suboptimal <italic toggle="yes">t</italic><sub>p</sub><sub>1</sub> value. The choice of a later-than-optimal intervention 1 trigger was found to negate the ability for an intervention 2 trigger to prevent increases in <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), suggesting that it is better to introduce the initial intervention earlier, rather than later, if the optimal intervention 1 trigger point is unknown. Extending the duration of intervention 1 and 2 did little to alter the optimal trigger points for all scenarios (electronic supplementary material, figures S6–S10).</p>
              <p>A large range of intervention 2 magnitudes (0 ≤ <italic toggle="yes">c</italic><sub>min2</sub> ≤ 1) were found to provide near-optimal reductions to <italic toggle="yes">I</italic><sub>max</sub>, on the condition that the magnitude of intervention 1 was sufficiently optimized for scenarios 2, 4 and 5 (<xref rid="RSTB20200282F3" ref-type="fig">figure 3</xref><italic toggle="yes">b</italic>). This suggests that for these scenarios, it is critical to focus on optimizing the initial intervention to minimize <italic toggle="yes">I</italic><sub>max</sub>. A different optimal parameter space was identified to minimize <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for these three scenarios, with strong reductions to both interventions 1 and 2 being favoured (<italic toggle="yes">c</italic><sub>min1</sub>/<italic toggle="yes">c</italic><sub>min2</sub> → 0). Scenario 3 displayed subtly different dynamics, with intervention 1 ideally being as strong as possible to minimize <italic toggle="yes">I</italic><sub>max</sub> (<italic toggle="yes">c</italic><sub>min1</sub> → 0) and an intermediate magnitude to minimize <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) (<italic toggle="yes">c</italic><sub>min1</sub> = 0.23). Scenario 1 was found to be optimal at an intermediate parameter space (<italic toggle="yes">c</italic><sub>min1</sub> = 0.26/0.62, <italic toggle="yes">c</italic><sub>min2</sub> = 0.52/0) for <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>), respectively. Increases in the duration of intervention 1 allowed greater reductions to <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for a given <italic toggle="yes">c</italic><sub>min1</sub>/<italic toggle="yes">c</italic><sub>min2</sub> parameter space, relative to baseline parameters (electronic supplementary material, figures S11–S15). The exception was scenario 3, with an increased intervention 1 duration also increasing <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) obtained over the explored <italic toggle="yes">c</italic><sub>min1</sub>/<italic toggle="yes">c</italic><sub>min2</sub> parameter space.</p>
            </sec>
            <sec id="s4">
              <label>4<x xml:space="preserve">. </x></label>
              <title>Discussion</title>
              <p>This study adds to the current epidemiological modelling work [<xref rid="RSTB20200282C9" ref-type="bibr">9</xref>–<xref rid="RSTB20200282C14" ref-type="bibr">14</xref>] to explore the concept of NPI optimization. We identified an optimal parameter space for all considered intervention scenarios, with each scenario capable of minimizing both <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for a given set of optimal parameter values. However, we note that the exact value of the optimal parameter space is highly nuanced, and often highly sensitive to changes to the explored model parameters.</p>
              <p>The optimal parameter space was found to be strongly influenced by the balance between the intervention peak timing and <italic toggle="yes">c</italic><sub>min</sub>. Matching the timing of an intervention to the epidemic peak has been explored previously [<xref rid="RSTB20200282C9" ref-type="bibr">9</xref>,<xref rid="RSTB20200282C10" ref-type="bibr">10</xref>]. However, we demonstrate that it is also necessary to match the timing of the epidemic peak with the greatest magnitude of the intervention (<italic toggle="yes">c</italic><sub>min</sub>/<italic toggle="yes">c</italic><sub>min1</sub>/<italic toggle="yes">c</italic><sub>min2</sub>) if reductions to <italic toggle="yes">β</italic>(<italic toggle="yes">t</italic>) vary. This can be intuitively observed by comparing scenario 2 (<italic toggle="yes">c</italic><sub>min</sub> at <italic toggle="yes">t</italic><sub>p</sub>) and scenario 3 (<italic toggle="yes">c</italic><sub>min</sub> at <italic toggle="yes">t</italic><sub>p</sub> + <italic toggle="yes">d<sub>t</sub></italic>) (<xref rid="RSTB20200282F2" ref-type="fig">figure 2</xref>), with scenario 2 being optimal at a later trigger point to coincide with the early <italic toggle="yes">c</italic><sub>min</sub> reduction and scenario 3 optimal with an earlier trigger to coincide with the later <italic toggle="yes">c</italic><sub>min</sub> reduction. We also note the existence of optimal intermediate <italic toggle="yes">c</italic><sub>min</sub> values facilitating the build-up of infection-induced, protective immunity during the intervention. This phenomenon is well reported in modelling literature, with time-limited interventions found to be optimal when <italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) is maintained near the threshold for sustained transmission (<italic toggle="yes">R</italic><sub>e</sub>(<italic toggle="yes">t</italic>) ≈ 1) [<xref rid="RSTB20200282C25" ref-type="bibr">25</xref>].</p>
              <p>However, attaining these optima in practice is likely to be difficult [<xref rid="RSTB20200282C10" ref-type="bibr">10</xref>]. The ongoing COVID-19 outbreak has highlighted the limited capacity of policymakers to effectively micromanage the course of an outbreak [<xref rid="RSTB20200282C29" ref-type="bibr">29</xref>]. Factors such as varying public compliance, imperfect disease surveillance, policy miscommunication, confounding parallel interventions and implementation lag between the introduced interventions and observable changes in disease prevalence will contribute to large levels of intervention implementation error [<xref rid="RSTB20200282C8" ref-type="bibr">8</xref>,<xref rid="RSTB20200282C30" ref-type="bibr">30</xref>,<xref rid="RSTB20200282C31" ref-type="bibr">31</xref>]. If placed in the context of the narrow parameter optima observed throughout this study, these effects will likely have substantial epidemiological consequences.</p>
              <p>An alternative approach could involve interventions that are more robust to implementation error, but less efficacious than the theoretically optimal intervention. An example of this can be observed in the single-intervention sensitivity analysis, with longer-than-optimal interventions providing robust, but less efficacious reductions to <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) for scenarios 3 and 4 relative to their optimal <italic toggle="yes">t</italic><sub>dur</sub> value (<xref rid="RSTB20200282F1" ref-type="fig">figure 1</xref><italic toggle="yes">b</italic>). Owing to the relative insensitivity of these robust interventions to imperfect parameter choices, these intervention strategies will likely excel in uncertain real-time outbreaks where the current epidemiological situation is often unknown. Parallels of these interventions can be observed in the ongoing COVID-19 outbreak, with recurring themes of ‘hit it hard and fast’ providing simple, yet robust advice to policymakers [<xref rid="RSTB20200282C15" ref-type="bibr">15</xref>,<xref rid="RSTB20200282C32" ref-type="bibr">32</xref>].</p>
              <p>We note that for a single time-limited intervention, it was not always optimal to intervene at a maximal strength or duration. For example, increasing <italic toggle="yes">t</italic><sub>dur</sub> for scenario 3 shifted the timing of <italic toggle="yes">c</italic><sub>min</sub> past the epidemic peak, lessening the impact of the NPI relative to optimal <italic toggle="yes">t</italic><sub>dur</sub> (<xref rid="RSTB20200282F1" ref-type="fig">figure 1</xref>). Additionally, NPIs were assumed to be time-limited, with even maximal- strength interventions ending before the termination of the model simulation, allowing rebounds in prevalence. This decision was made because of the infeasible nature of having an indefinite implementation of severe restrictions owing to societal disruptions. However, we note that when considered in the context of a robust, but suboptimal intervention, intervening maximally to increase <italic toggle="yes">t</italic><sub>dur</sub> and minimize <italic toggle="yes">c</italic><sub>min</sub> can be considered the most efficacious strategy to reduce <italic toggle="yes">I</italic><sub>max</sub> or <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) (figures <xref rid="RSTB20200282F1" ref-type="fig">1</xref> and <xref rid="RSTB20200282F2" ref-type="fig">2</xref>).</p>
              <p>Similarly, for the multi-intervention scenario, an earlier and stronger intervention can provide reductions to <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) under suboptimal circumstances as part of a robust intervention (<xref rid="RSTB20200282F3" ref-type="fig">figure 3</xref>). However, this only holds true in the context of the initial intervention, with this acting as a delaying action, allowing successive interventions to compensate and further reduce <italic toggle="yes">I</italic><sub>max</sub> and <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>). This highlights the additional role of robust interventions to permit future decision-making when the current epidemiological situation is uncertain. This has practical consequences, with policymakers able to use an earlier intervention to delay the epidemic peak if the optimal intervention strategy is unknown, providing time for the build-up of healthcare capacity and the opportunity for later interventions to course-correct.</p>
              <p>We note that population ‘lockdown’ measures have been presented as an integral part of a package of measures, used to drive down the level of infection and ‘buy’ time for the introduction of more sustainable measures, such as contact tracing or vaccination [<xref rid="RSTB20200282C33" ref-type="bibr">33</xref>,<xref rid="RSTB20200282C34" ref-type="bibr">34</xref>]. We note that in the context of delaying the epidemic peak, it is universally optimal to introduce the initial ‘lockdown’ measures earlier, more strongly and for as long as necessary, until more sustainable intervention measures can be introduced indefinitely (electronic supplementary material, figure S16). However, this also highlights the importance of prioritizing the development of these sustainable measures, with the harsh consequences of severe, lengthy NPI measures making indefinite delaying actions expensive and ultimately unsustainable.</p>
              <p>We note that an SIR model was one of many model structures considered to model the optimization of COVID-19 NPI strategies. An SEIR framework can be considered a more accurate description of the epidemiological characteristics of SARS-CoV-2, with a non-infectious ‘exposed’ state preceding infectiousness. We explored the inclusion of an exposed state, which shifted the timing of the optimal intervention to a later point, but did little to change the qualitative patterns observed when using the SIR framework (electronic supplementary material, figure S17). An assumption of lifelong immunity was also made following SARS-CoV-2 infection. We note that inclusion of a SIRS framework with differing levels of waning immunity would result in negligible impact on the optimal parameter space to minimize <italic toggle="yes">I</italic><sub>max</sub> relative to the original SIR model (electronic supplementary material, figure S18). This is likely due to the similar importance of controlling the initial epidemic wave to minimize <italic toggle="yes">I</italic><sub>max</sub> for both SIR and SIRS models. However, a different optimal parameter space to minimize <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>) was observed, likely as a result of the replenishment of susceptibles and long-term endemicity of COVID-19. Care must, therefore, be taken when interpreting the results of this study with regard to the long-term dynamics of COVID-19, especially owing to the ongoing uncertainty regarding the presence of long-term immunizing infection following SARS-CoV-2 infection. Owing to the large levels of uncertainty with regard to the immunological and transmission characteristics of SARS-CoV-2, and with the aim of this study to describe the existence and qualitative patterns of intervention optima, and not forecast or describe the exact timing, the use of a SIR model was deemed justifiable for this analysis. However, we note that for future predictive models that look to accurately identify the optimal parameter space, the integration of potentially all of the aforementioned model structures will likely be necessary using a SEIIRS or SEIRS model.</p>
              <p>The socio-economic cost of each intervention was also not considered in this analysis. Factors such as adherence have a large impact on intervention efficacy [<xref rid="RSTB20200282C23" ref-type="bibr">23</xref>], and the inclusion of these factors in the model may potentially provide support for NPI strategies with dedicated ramping or pulsing periods, which aim to partially mitigate the socio-economic effects and societal disruption of strong NPIs. A relatively simple disease metric was also used for this study, with an optimal intervention able to reduce the maximum peak prevalence, <italic toggle="yes">I</italic><sub>max</sub>, and attack rate, <italic toggle="yes">I<sub>c</sub></italic>(<italic toggle="yes">t</italic><sub>max</sub>). While outside of the scope of this study, the use of other epidemiologically relevant outcome measures such as occupied ICU capacity or mortality per 100 000 population may be of interest when investigating optimal COVID-19 interventions in a more policy-relevant context. This could also be complemented by an exploration into the impact of individual or population-level variation of risk on intervention optimization [<xref rid="RSTB20200282C35" ref-type="bibr">35</xref>–<xref rid="RSTB20200282C37" ref-type="bibr">37</xref>].</p>
              <p>NPI optimization has been highlighted in this study as a powerful tool to greatly mitigate the epidemiological impacts of a COVID-19 outbreak. This can be considered of significant relevance, with the recent reinstitution of NPIs and stricter measures being used to combat resurgent outbreaks. However, the results described in this study are highly nuanced, with narrow intervention optima and a number of other factors likely preventing the trajectory of an epidemic conforming uniformly to the dynamics observed in this study. We highlight robust interventions as an alternative policy option, with these interventions being less prone to implementation error but potentially suboptimal compared with theoretically optimal strategies. These interventions have the additional benefit of being a risk-averse approach, often favourable during the initial stages of the outbreak, where the impact of risky public health policy can lead to disastrous consequences. We also note that the sensitivity analysis-based framework used in this study is applicable to other immunizing pathogens, where transmission can be mitigated through NPIs. This approach has particular benefit in emerging outbreak scenarios where the rapid identification of optimal (or even robust) NPI implementation can contribute to the evidence base for outbreak response and reduce indecisiveness.</p>
              <p>Finally, we stress that it was not the intention of this study to propose any one strategy as a singular policy option for COVID-19 control. The evidence from this study should be taken into context with the work tirelessly undertaken by the wider epidemiological and modelling community. It is only through this collaboration and synthesis that effective and altruistic public health policy can be generated to combat the COVID-19 pandemic.</p>
            </sec>
            <sec id="s5">
              <label>5<x xml:space="preserve">. </x></label>
              <title>In context</title>
              <p>The work presented in this manuscript was originally submitted as a series of three technical briefings to SPI-M in early-March 2020. The study was motivated by the prevailing need to understand the potential impact resulting from severe non-pharmaceutical interventions on the transmission dynamics of COVID-19 and the consequences of releasing NPIs. We note that this work was conducted before the initiation of the first UK lockdown (23 March 2020). These three technical briefings were as follows:</p>
              <p>
                <list list-type="simple">
                  <list-item>
                    <label>1<x xml:space="preserve">. </x><x xml:space="preserve"> </x></label>
                    <p>Technical briefing 1—Time-limited social distancing measures and the shape of the epidemic curve (29 February 2020).</p>
                  </list-item>
                  <list-item>
                    <label>2<x xml:space="preserve">. </x><x xml:space="preserve"> </x></label>
                    <p>Technical briefing 2—Optimizing trigger times for social distancing measures (SDMs) (4 March 2020).</p>
                  </list-item>
                  <list-item>
                    <label>3<x xml:space="preserve">. </x><x xml:space="preserve"> </x></label>
                    <p>Technical briefing 3—Uncertainty about timings of SDMs (4 March 2020).</p>
                  </list-item>
                </list>
              </p>
              <p>The original core analysis conducted for SPI-M utilizsed parameter values that were contemporary as of March 2020. This includes an <italic toggle="yes">R</italic><sub>0</sub> value that was later updated from 2 to 2.8 in the formalized manuscript in July/August 2020 [<xref rid="RSTB20200282C17" ref-type="bibr">17</xref>]. This reflects the substantial improvements in knowledge regarding the epidemiology and immunological characteristics of COVID-19 in this later period.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgements</title>
              <p>We thank Ms Hannah Lepper for the useful comments during the drafting of this paper and the initial stages of model implementation.</p>
            </ack>
            <sec id="s6">
              <title>Data accessibility</title>
              <p>Code used to generate/run all model simulations in this study can be found in the GitHub repository: <uri xlink:href="https://github.com/alexmorgan1995/NPI_Analysis">https://github.com/alexmorgan1995/NPI_Analysis</uri>.</p>
            </sec>
            <sec id="s7">
              <title>Authors' contributions</title>
              <p>A.L.K.M. participated in the study design, carried out model analysis and drafted the manuscript. B.A.D.v.B. participated in the study design and provided feedback on manuscript drafts. M.E.J.W. participated in the study design and provided feedback on manuscript drafts. G.F.M. provided feedback on manuscript drafts.</p>
            </sec>
            <sec id="s8">
              <title>Competing interests</title>
              <p>We declare we have no competing interests.</p>
            </sec>
            <sec id="s9">
              <title>Funding</title>
              <p>This study was supported by a Wellcome Trust PhD grant (215094/Z/18/Z) and by the University of Edinburgh.</p>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="RSTB20200282C1">
                <label>1<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab>. <year>2020</year><source>Nonpharmaceutical interventions (NPIs).</source><publisher-loc>USA</publisher-loc>: <publisher-name>US Department of Health &amp; Human Services</publisher-name>. <comment>See <uri xlink:href="https://www.cdc.gov/nonpharmaceutical-interventions/index.html">https://www.cdc.gov/nonpharmaceutical-interventions/index.html</uri></comment> (<comment>updated 27 April 2020, accessed 20 July 2020)</comment>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C2">
                <label>2<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="book"><collab>Cabinet Office</collab>. <year>2020</year><source>Guidance: staying at home and away from others (social distancing)</source>. <publisher-loc>London, UK</publisher-loc>: <publisher-name>Cabinet Office</publisher-name><comment>. See <uri xlink:href="https://www.gov.uk/government/publications/full-guidance-on-staying-at-home-and-away-from-others/full-guidance-on-staying-at-home-and-away-from-others">https://www.gov.uk/government/publications/full-guidance-on-staying-at-home-and-away-from-others/full-guidance-on-staying-at-home-and-away-from-others</uri></comment> (<comment>updated 1 May 2020, accessed 4 August 2020)</comment>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C3">
                <label>3<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nicola</surname><given-names>M</given-names></string-name>, <string-name><surname>Alsafi</surname><given-names>Z</given-names></string-name>, <string-name><surname>Sohrabi</surname><given-names>C</given-names></string-name>, <string-name><surname>Kerwan</surname><given-names>A</given-names></string-name>, <string-name><surname>Al-Jabir</surname><given-names>A</given-names></string-name>, <string-name><surname>Iosifidis</surname><given-names>C</given-names></string-name>, <string-name><surname>Agha</surname><given-names>M</given-names></string-name>, <string-name><surname>Agha</surname><given-names>R</given-names></string-name></person-group>. <year>2020</year><article-title>The socio-economic implications of the coronavirus pandemic (COVID-19): a review</article-title>. <source>Int. J. Surg.</source><volume><bold>78</bold></volume>, <fpage>185</fpage>-<lpage>193</lpage>. (<pub-id pub-id-type="doi">10.1016/j.ijsu.2020.04.018</pub-id>)<pub-id pub-id-type="pmid">32305533</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C4">
                <label>4<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pierce</surname><given-names>M</given-names></string-name><etal>et al</etal></person-group>. <year>2020</year><article-title>Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population</article-title>. <source>Lancet Psychiatry</source><volume><bold>7</bold></volume>, <fpage>883</fpage>-<lpage>892</lpage>. (<pub-id pub-id-type="doi">10.1016/S2215-0366(20)30308-4</pub-id>)<pub-id pub-id-type="pmid">32707037</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C5">
                <label>5<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pfefferbaum</surname><given-names>B</given-names></string-name>, <string-name><surname>North</surname><given-names>CS</given-names></string-name></person-group>. <year>2020</year><article-title>Mental health and the Covid-19 pandemic</article-title>. <source>N. Engl. J. Med.</source><volume><bold>383</bold></volume>, <fpage>510</fpage>-<lpage>512</lpage>. (<pub-id pub-id-type="doi">10.1056/NEJMp2008017</pub-id>)<pub-id pub-id-type="pmid">32283003</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C6">
                <label>6<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dickens</surname><given-names>BL</given-names></string-name><etal>et al.</etal></person-group><year>2020</year><article-title>Modelling lockdown and exit strategies for COVID-19 in Singapore</article-title>. <source>Lancet Region Health. West. Pac.</source><volume><bold>1</bold></volume>, <fpage>e100004</fpage>. (<pub-id pub-id-type="doi">10.1016/j.lanwpc.2020.100004.</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C7">
                <label>7<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Daly</surname><given-names>M</given-names></string-name></person-group>. <year>2020</year><comment>Coronavirus: earlier Scottish lockdown ‘could have prevented 2,000 deaths'. <italic toggle="yes">BBC News</italic>. See <uri xlink:href="https://www.bbc.co.uk/news/uk-scotland-52617895">https://www.bbc.co.uk/news/uk-scotland-52617895</uri></comment> (<comment>updated 14 June 2020, accessed 10 August 2020)</comment>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C8">
                <label>8<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Islam</surname><given-names>N</given-names></string-name>, <string-name><surname>Sharp</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Chowell</surname><given-names>G</given-names></string-name>, <string-name><surname>Shabnam</surname><given-names>S</given-names></string-name>, <string-name><surname>Kawachi</surname><given-names>I</given-names></string-name>, <string-name><surname>Lacey</surname><given-names>B</given-names></string-name>, <string-name><surname>Massaro</surname><given-names>JM</given-names></string-name>, <string-name><surname>D'Agostino</surname><given-names>RB</given-names></string-name>, <string-name><surname>White</surname><given-names>M</given-names></string-name></person-group>. <year>2020</year><article-title>Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries</article-title>. <source>BMJ</source><volume><bold>370</bold></volume>, <fpage>m2743</fpage>. (<pub-id pub-id-type="doi">10.1136/bmj.m2743</pub-id>)<pub-id pub-id-type="pmid">32669358</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C9">
                <label>9<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Di Lauro</surname><given-names>F</given-names></string-name>, <string-name><given-names>Kiss</given-names><surname>IZ</surname></string-name>, <string-name><given-names>Miller</given-names><surname>JC</surname></string-name></person-group>. <year>2021</year><article-title>Optimal timing of one-shot interventions for epidemic control</article-title>. <comment><italic toggle="yes">PLoS Comput. Biol.</italic><bold>17</bold>, e1008763.</comment> (<pub-id pub-id-type="doi">10.1371/journal.pcbi.1008763</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C10">
                <label>10<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><given-names>Morris</given-names><surname>DH</surname></string-name>, <string-name><given-names>Rossine</given-names><surname>FW</surname></string-name>, <string-name><given-names>Plotkin</given-names><surname>JB</surname></string-name>, <string-name><surname>Levin</surname><given-names>SA.</given-names></string-name></person-group><year>2021</year><article-title>Optimal, near-optimal, and robust epidemic control</article-title>. <comment><italic toggle="yes">Commun. Phys.</italic><bold>4</bold>, 78.</comment> (<pub-id pub-id-type="doi">10.1038/s42005-021-00570-y</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C11">
                <label>11<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Bin</surname><given-names>M</given-names></string-name><etal>et al</etal></person-group>. <year>2020</year><comment>On fast multi-shot COVID-19 interventions for post lock-down mitigation. <italic toggle="yes">arXiv</italic>, 2003.09930. See <uri xlink:href="https://arxiv.org/abs/2003.09930v5">https://arxiv.org/abs/2003.09930v5</uri></comment>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C12">
                <label>12<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rawson</surname><given-names>T</given-names></string-name>, <string-name><surname>Brewer</surname><given-names>T</given-names></string-name>, <string-name><surname>Veltcheva</surname><given-names>D</given-names></string-name>, <string-name><surname>Huntingford</surname><given-names>C</given-names></string-name>, <string-name><surname>Bonsall</surname><given-names>MB</given-names></string-name></person-group>. <year>2020</year><article-title>How and when to end the COVID-19 lockdown: an optimization approach</article-title>. <source>Front. Public Health</source><volume><bold>8</bold></volume>, <fpage>262</fpage>. (<pub-id pub-id-type="doi">10.3389/fpubh.2020.00262</pub-id>)<pub-id pub-id-type="pmid">32587844</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C13">
                <label>13<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><given-names>Gevertz</given-names><surname>JL</surname></string-name>, <string-name><given-names>Greene</given-names><surname>JM</surname></string-name>, <string-name><given-names>Sanchez-Tapia</given-names><surname>CH</surname></string-name>, <string-name><surname>Sontag</surname><given-names>ED.</given-names></string-name></person-group><year>2021</year><article-title>A novel COVID-19 epidemiological model with explicit susceptible and asymptomatic isolation compartments reveals unexpected consequences of timing social distancing</article-title>. <comment><italic toggle="yes">J. Theor. Biol.</italic><bold>510</bold>, 110539.</comment> (<pub-id pub-id-type="doi">10.1016/j.jtbi.2020.110539</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C14">
                <label>14<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Miclo</surname><given-names>L</given-names></string-name>, <string-name><surname>Spiro</surname><given-names>D</given-names></string-name>, <string-name><surname>Weibull</surname><given-names>J</given-names></string-name></person-group>. <year>2020</year><comment>Optimal epidemic suppression under an ICU constraint. <italic toggle="yes">arXiv</italic>, 2005.01327</comment>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C15">
                <label>15<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="book"><collab>World Health Organization</collab>. <year>2020</year><source>New Zealand takes early and hard action to tackle COVID-19</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>. <comment>See <uri xlink:href="https://www.who.int/westernpacific/news/feature-stories/detail/new-zealand-takes-early-and-hard-action-to-tackle-covid-19">https://www.who.int/westernpacific/news/feature-stories/detail/new-zealand-takes-early-and-hard-action-to-tackle-covid-19</uri></comment> (<comment>updated 15 July 2020, accessed 6 December 2020</comment>).</mixed-citation>
              </ref>
              <ref id="RSTB20200282C16">
                <label>16<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kermack</surname><given-names>WO</given-names></string-name>, <string-name><surname>McKendrick</surname><given-names>AG</given-names></string-name></person-group>. <year>1927</year><article-title>A contribution to the mathematical theory of epidemics</article-title>. <source>Proc. R. Soc. Lond. A</source><volume><bold>115</bold></volume>, <fpage>700</fpage>-<lpage>721</lpage>. (<pub-id pub-id-type="doi">10.1098/rspa.1927.0118</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C17">
                <label>17<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pan</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group><year>2020</year><article-title>Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China</article-title>. <source>JAMA</source><volume><bold>323</bold></volume>, <fpage>1915</fpage>-<lpage>1923</lpage>. (<pub-id pub-id-type="doi">10.1001/jama.2020.6130</pub-id>)<pub-id pub-id-type="pmid">32275295</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C18">
                <label>18<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Pellis</surname><given-names>L</given-names></string-name><etal>et al</etal></person-group>. <year>2020</year><comment>Challenges in control of COVID-19: short doubling time and long delay to effect of interventions. <italic toggle="yes">arXiv</italic>, 2020.04.12.20059972</comment>. (<pub-id pub-id-type="doi">10.1101/2020.04.12.20059972</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C19">
                <label>19<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petersen</surname><given-names>E</given-names></string-name>, <string-name><surname>Koopmans</surname><given-names>M</given-names></string-name>, <string-name><surname>Go</surname><given-names>U</given-names></string-name>, <string-name><surname>Hamer</surname><given-names>DH</given-names></string-name>, <string-name><surname>Petrosillo</surname><given-names>N</given-names></string-name>, <string-name><surname>Castelli</surname><given-names>F</given-names></string-name>, <string-name><surname>Storgaard</surname><given-names>M</given-names></string-name>, <string-name><surname>Al Khalili</surname><given-names>S</given-names></string-name>, <string-name><surname>Simonsen</surname><given-names>L</given-names></string-name></person-group>. <year>2020</year><article-title>Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics</article-title>. <source>Lancet Infect. Dis.</source><volume><bold>20</bold></volume>, <fpage>e238</fpage>-<lpage>e244</lpage>. (<pub-id pub-id-type="doi">10.1016/S1473-3099(20)30484-9</pub-id>)<pub-id pub-id-type="pmid">32628905</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C20">
                <label>20<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name><surname>Liu</surname><given-names>JM</given-names></string-name>, <string-name><surname>Dong</surname><given-names>XP</given-names></string-name>, <string-name><surname>McGoogan</surname><given-names>JM</given-names></string-name>, <string-name><surname>Wu</surname><given-names>ZY</given-names></string-name></person-group>. <year>2020</year><article-title>COVID-19 seeding time and doubling time model: an early epidemic risk assessment tool</article-title>. <source>Infect. Dis. Poverty</source><volume><bold>9</bold></volume>, <fpage>76</fpage>. (<pub-id pub-id-type="doi">10.1186/s40249-020-00685-4</pub-id>)<pub-id pub-id-type="pmid">32576256</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C21">
                <label>21<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flaxman</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group><year>2020</year><article-title>Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe</article-title>. <source>Nature</source><volume><bold>584</bold></volume>, <fpage>257</fpage>-<lpage>261</lpage>. (<pub-id pub-id-type="doi">10.1038/s41586-020-2405-7</pub-id>)<pub-id pub-id-type="pmid">32512579</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C22">
                <label>22<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Anderson</surname><given-names>RM</given-names></string-name>, <string-name><surname>May</surname><given-names>RM</given-names></string-name></person-group>. <year>1991</year><source>Infectious diseases of humans: dynamics and control</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C23">
                <label>23<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davies</surname><given-names>NG</given-names></string-name>, <string-name><surname>Kucharski</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Eggo</surname><given-names>RM</given-names></string-name>, <string-name><surname>Gimma</surname><given-names>A</given-names></string-name>, <string-name><surname>Edmunds</surname><given-names>WJ</given-names></string-name></person-group><article-title>.</article-title><year>2020</year><article-title>Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study</article-title>. <source>Lancet Public Health</source><volume><bold>5</bold></volume>, <fpage>e375</fpage>-<lpage>e385</lpage>. (<pub-id pub-id-type="doi">10.1016/S2468-2667(20)30133-X</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C24">
                <label>24<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Flaxman</surname><given-names>S</given-names></string-name><etal>et al</etal></person-group>. <year>2020</year><comment><italic toggle="yes">Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries</italic>. London, UK: Imperial College London.</comment></mixed-citation>
              </ref>
              <ref id="RSTB20200282C25">
                <label>25<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anderson</surname><given-names>RM</given-names></string-name>, <string-name><surname>Heesterbeek</surname><given-names>H</given-names></string-name>, <string-name><surname>Klinkenberg</surname><given-names>D</given-names></string-name>, <string-name><surname>Hollingsworth</surname><given-names>TD</given-names></string-name></person-group>. <year>2020</year><article-title>How will country-based mitigation measures influence the course of the COVID-19 epidemic?</article-title><source>Lancet</source><volume><bold>395</bold></volume>, <fpage>931</fpage>-<lpage>934</lpage>. (<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30567-5</pub-id>)<pub-id pub-id-type="pmid">32164834</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C26">
                <label>26<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="book"><collab>R Development Core Team</collab>. <year>2020</year><source>R: a language and environment for statistical computing</source> (<comment>v3.6.2</comment>). <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>. See <comment><uri xlink:href="https://www.r-project.org/">https://www.r-project.org/</uri></comment>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C27">
                <label>27<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="book"><collab>RStudio Team</collab>. <year>2020</year><source>RStudio: integrated development for R</source> (<comment>v1.3.959</comment>). <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>RStudio, PBC</publisher-name>. <comment>See <uri xlink:href="https://rstudio.com/">https://rstudio.com/</uri></comment>.</mixed-citation>
              </ref>
              <ref id="RSTB20200282C28">
                <label>28<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soetaert</surname><given-names>KE</given-names></string-name>, <string-name><surname>Petzoldt</surname><given-names>T</given-names></string-name>, <string-name><surname>Setzer</surname><given-names>RW</given-names></string-name></person-group>. <year>2010</year><article-title>Solving differential equations in R: package deSolve</article-title>. <source>J. Stat. Softw.</source><volume><bold>33</bold></volume>, 1–25. (<pub-id pub-id-type="doi">10.18637/jss.v033.i09</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C29">
                <label>29<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hunter</surname><given-names>DJ</given-names></string-name></person-group>. <year>2020</year><article-title>Covid-19 and the stiff upper lip—the pandemic response in the United Kingdom</article-title>. <source>N. Engl. J. Med.</source><volume><bold>382</bold></volume>, <fpage>e31</fpage>. (<pub-id pub-id-type="doi">10.1056/NEJMp2005755</pub-id>)<pub-id pub-id-type="pmid">32197002</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C30">
                <label>30<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elliot</surname><given-names>AJ</given-names></string-name><etal>et al.</etal></person-group><year>2020</year><article-title>The COVID-19 pandemic: a new challenge for syndromic surveillance</article-title>. <source>Epidemiol. Infect.</source><volume><bold>148</bold></volume>, <fpage>e122</fpage>. (<pub-id pub-id-type="doi">10.1017/S0950268820001314</pub-id>)<pub-id pub-id-type="pmid">32614283</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C31">
                <label>31<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chang</surname><given-names>SL</given-names></string-name>, <string-name><surname>Harding</surname><given-names>N</given-names></string-name>, <string-name><surname>Zachreson</surname><given-names>C</given-names></string-name>, <string-name><surname>Cliff</surname><given-names>OM</given-names></string-name>, <string-name><surname>Prokopenko</surname><given-names>M</given-names></string-name></person-group>. <year>2020</year><article-title>Modelling transmission and control of the COVID-19 pandemic in Australia</article-title>. <source>Nat. Commun.</source><volume><bold>11</bold></volume>, <fpage>5770</fpage>. (<pub-id pub-id-type="doi">10.1038/s41467-020-19393-6.</pub-id>)<pub-id pub-id-type="pmid">33188192</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C32">
                <label>32<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baker</surname><given-names>MG</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>N</given-names></string-name>, <string-name><surname>Anglemyer</surname><given-names>A</given-names></string-name></person-group>. <year>2020</year><article-title>Successful elimination of Covid-19 transmission in New Zealand</article-title>. <source>N. Engl. J. Med.</source><volume><bold>383</bold></volume>, <fpage>e56</fpage>. (<pub-id pub-id-type="doi">10.1056/NEJMc2025203</pub-id>)<pub-id pub-id-type="pmid">32767891</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C33">
                <label>33<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferretti</surname><given-names>L</given-names></string-name>, <string-name><surname>Wymant</surname><given-names>C</given-names></string-name>, <string-name><surname>Kendall</surname><given-names>M</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>L</given-names></string-name>, <string-name><surname>Nurtay</surname><given-names>A</given-names></string-name>, <string-name><surname>Abeler-Dorner</surname><given-names>L</given-names></string-name>, <string-name><surname>Parker</surname><given-names>M</given-names></string-name>, <string-name><surname>Bonsall</surname><given-names>D</given-names></string-name>, <string-name><surname>Fraser</surname><given-names>C</given-names></string-name></person-group>. <year>2020</year><article-title>Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing</article-title>. <source>Science</source><volume><bold>368</bold></volume>, <fpage>eabb6936</fpage>. (<pub-id pub-id-type="doi">10.1126/science.abb6936</pub-id>)<pub-id pub-id-type="pmid">32234805</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C34">
                <label>34<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lurie</surname><given-names>N</given-names></string-name>, <string-name><surname>Saville</surname><given-names>M</given-names></string-name>, <string-name><surname>Hatchett</surname><given-names>R</given-names></string-name>, <string-name><surname>Halton</surname><given-names>J</given-names></string-name></person-group>. <year>2020</year><article-title>Developing Covid-19 vaccines at pandemic speed</article-title>. <source>N. Engl. J. Med.</source><volume><bold>382</bold></volume>, <fpage>1969</fpage>-<lpage>1973</lpage>. (<pub-id pub-id-type="doi">10.1056/NEJMp2005630</pub-id>)<pub-id pub-id-type="pmid">32227757</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C35">
                <label>35<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Gomes</surname><given-names>MGM</given-names></string-name>, <string-name><surname>Aguas</surname><given-names>R</given-names></string-name>, <string-name><surname>Corder</surname><given-names>RM</given-names></string-name>, <string-name><surname>King</surname><given-names>JG</given-names></string-name>, <string-name><surname>Langwig</surname><given-names>KE</given-names></string-name>, <string-name><surname>Souto-Maior</surname><given-names>C</given-names></string-name>, <string-name><surname>Carneiro</surname><given-names>J</given-names></string-name>, <string-name><surname>Ferreira</surname><given-names>MU</given-names></string-name>, <string-name><surname>Penha-Goncalves</surname><given-names>C</given-names></string-name></person-group>. <year>2020</year><comment>Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold. <italic toggle="yes">medRxiv</italic>, 2020.04.27.20081893</comment>. (<pub-id pub-id-type="doi">10.1101/2020.04.27.20081893</pub-id>)</mixed-citation>
              </ref>
              <ref id="RSTB20200282C36">
                <label>36<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Britton</surname><given-names>T</given-names></string-name>, <string-name><surname>Ball</surname><given-names>F</given-names></string-name>, <string-name><surname>Trapman</surname><given-names>P</given-names></string-name></person-group>. <year>2020</year><article-title>A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2</article-title>. <source>Science</source><volume><bold>369</bold></volume>, <fpage>846</fpage>-<lpage>849</lpage>. (<pub-id pub-id-type="doi">10.1126/science.abc6810</pub-id>)<pub-id pub-id-type="pmid">32576668</pub-id></mixed-citation>
              </ref>
              <ref id="RSTB20200282C37">
                <label>37<x xml:space="preserve">. </x></label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davies</surname><given-names>NG</given-names></string-name>, <string-name><surname>Klepac</surname><given-names>P</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Prem</surname><given-names>K</given-names></string-name>, <string-name><surname>Jit</surname><given-names>M</given-names></string-name></person-group><article-title>,</article-title><person-group person-group-type="author"><string-name><surname>Eggo</surname><given-names>RM</given-names></string-name></person-group><etal>.</etal><year>2020</year><article-title>Age-dependent effects in the transmission and control of COVID-19 epidemics</article-title>. <source>Nat. Med.</source><volume><bold>26</bold></volume>, <fpage>1205</fpage>-<lpage>1211</lpage>. (<pub-id pub-id-type="doi">10.1038/s41591-020-0962-9</pub-id>)</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
